3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Glioma
3
Wilms Tumor
2
Prostatic Neoplasms
2
Glioblastoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Brain Neoplasms
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Solitary Fibrous Tumor, Pleural
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neuroblastoma
1
Neoplasms
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Germinoma
1
Ganglioneuroblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Ependymoma
1
Down Syndrome
1
Diabetes Insipidus
1
Central Nervous System Nongerminomatous Germ Cell Tumor
1
Central Nervous System Neoplasms
1
Interventions
Oxaliplatin
64
pembrolizumab
48
Fluorouracil
44
Capecitabine
38
Nivolumab
33
Leucovorin
32
Paclitaxel
28
Trastuzumab
19
Docetaxel
18
Cisplatin
18
S 1 (combination)
16
Bevacizumab
15
Ramucirumab
13
Irinotecan
13
Drug Therapy
13
tislelizumab
12
Cyclophosphamide
12
fludarabine
10
Carboplatin
10
Radiotherapy
9
Magnetic Resonance Spectroscopy
9
trastuzumab deruxtecan
8
sintilimab
8
Specimen Handling
8
Biopsy
8
atezolizumab
7
Surgical Procedures, Operative
7
Gemcitabine
7
zolbetuximab
6
durvalumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Radiotherapy, Conformal
×
1 year
×
Clear all
No trials found.